A potential role for GPR55 in gastrointestinal functions.
Despite sharing little homology (10-15%) with cannabinoid-1 (CB(1)) and cannabinoid-2 (CB(2)) receptors, the G protein-coupled receptor 55 (GPR55) was initially thought to be a new member of the cannabinoid receptor family. Apart from being activated by various exogenous cannabinoids, GPR55 is also activated by endocannabinoids like anandamide, which is found in organs with high GPR55 expression such as the brain and the gastrointestinal (GI) tract. The phylogenetic distance to the classical CB receptors and its pharmacological responsiveness to certain cannabinoids suggests that GPR55 may constitute a novel class of cannabinoid receptors. GPR55 influences mechanisms in the nervous system, vasculature, kidney and bone. Recent research revealed that GPR55 is also involved in cancer development and inflammatory pain. Because of its presence in the GI tract, several studies have started to focus on the involvement of GPR55 in the physiology and pathophysiology of the gut. The following article intends to discuss the potential role of GPR55 in GI functions.
Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria.
Rudolf
R
Schicho
Martin
M
Storr
D000818:Animals; D002186:Cannabinoids / Q000494:pharmacology; D063388:Endocannabinoids / Q000378:metabolism; D005767:Gastrointestinal Diseases / Q000503:physiopathology*; D041981:Gastrointestinal Tract / Q000502:physiology* / Q000503:physiopathology; D015870:Gene Expression; D006801:Humans; D043882:Receptors, Cannabinoid / Q000502:physiology; D043562:Receptors, G-Protein-Coupled / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*
D002186:Cannabinoids; D063388:Endocannabinoids; C524885:GPR55 protein, human; D043882:Receptors, Cannabinoid; D043562:Receptors, G-Protein-Coupled